How did GRFX's revenue and expenses shift in Q2 2023?
5/9/2025 00:43am
Aime
Graphex Group (GRFX) experienced a significant decline in revenue and reported a total revenue of -$17.95 million for Q2 2023, with total expenses amounting to $01. This indicates a substantial financial strain for the company during this period.
GRFX Total Revenue, Total Expenses
单位
Source:
1.
GRFX Revenue and Expenses in Q2 2023
more
less
For you
What are the short-term price targets set by analysts covering Redhill Biopharma?
What are the short-term technical indicators suggesting for Redhill Biopharma?
Is there any unusual options activity or capital flow surrounding Redhill Biopharma stock?
Are there any significant news or announcements expected next week regarding Redhill Biopharma?
How has Redhill Biopharma's stock performed compared to the overall market recently?
Explore
Screener
What are the best stocks to buy now?
Analysis
Aple Rating chart
Learn
Advanced technical indicators and how they are calculated and utilized